Vimta Labs Share Price

NSE
VIMTALABS •
BUY

1W Return

1M Return

6M Return

1Y Return

3Y Return

The current prices are delayed, login or Open Demat Account for live prices.
Start SIP in Vimta Labs Ltd
Stock Performance
52 Week Low - High
Today’s Low - High

Open

Prev. Close

Total Traded Value

View details of Market Depth
Fundamental

Market Cap (in crs)

Face Value

Turnover (in lacs)

Key Metrics
Qtr Change %
Near 52W High of ₹804.25
53.1
TTM PE Ratio
Below industry Median
34
Price to Book Ratio
Above industry Median
5.3
Dividend yield 1yr %
Below industry Median
0.3
TTM PEG Ratio
PEG TTM is much higher than 1
1.6

Vimta Labs Ltd Key Financials

View more

*All values are in ₹ Cr.

*All values are in ₹ Cr.

*All values are in ₹ Cr.

*All values are in ₹ Cr.

Vimta Labs Ltd Quarterly Revenue

Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
84.74 Cr
81.76 Cr
79.69 Cr
81.68 Cr
73.41 Cr

Vimta Labs Ltd Yearly Revenue

Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020
322.27 Cr
321.63 Cr
279.73 Cr
211.51 Cr
183.73 Cr

Vimta Labs Ltd Quarterly Net Profit/Loss

Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
17.02 Cr
12.28 Cr
12.35 Cr
10.13 Cr
6.33 Cr

Vimta Labs Ltd Yearly Net Profit/Loss

Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020
41.01 Cr
48.17 Cr
41.33 Cr
21.4 Cr
6.84 Cr

Vimta Labs Ltd shareholding Pattern

Promoter
36.9%
Foreign Institutions
3.3%
Public
59.8%
Promoter
36.9%
Foreign Institutions
5.2%
Mutual Funds
1.5%
Domestic Institutions
1.5%
Public
56.4%
Promoter
36.9%
Foreign Institutions
5.1%
Mutual Funds
1.5%
Domestic Institutions
1.5%
Public
56.4%
Promoter
37%
Foreign Institutions
2.9%
Mutual Funds
1.5%
Domestic Institutions
1.5%
Public
58.6%
Promoter
37%
Foreign Institutions
2.7%
Mutual Funds
1.5%
Domestic Institutions
1.5%
Public
58.8%
Promoter
37.2%
Foreign Institutions
2.7%
Mutual Funds
1.5%
Domestic Institutions
2.1%
Public
57.9%

Vimta Labs Ltd Technical Analysis

Moving Averages Analysis
Moving Averages Analysis
Current Price
Bullish Moving Averages
16
Bearish Moving Averages
0
5Day EMA
749.50
10Day EMA
715.10
12Day EMA
702.50
20Day EMA
665.20
26Day EMA
647.40
50Day EMA
610.60
100Day EMA
575.80
200Day EMA
539.10
5Day SMA
760.70
10Day SMA
712.50
20Day SMA
635.10
30Day SMA
607.80
50Day SMA
594.20
100Day SMA
566.70
150Day SMA
542.00
200Day SMA
526.70
Delivery & Volume

Delivery & Volume

PeriodCombined Delivery VolumeNSE+BSE Traded Volume
Day Rs
52704 Rs
112726 Rs
Week Rs
78732 Rs
163336 Rs
Month Rs
75525 Rs
202005 Rs
Resistance & Support
756.08
Pivot
Resistance
First Resistance
784.57
Second Resistance
804.48
Third Resistance
832.97
Support
First Support
736.17
Second support
707.68
Third Support
687.77
Relative Strength Index
71.71
Money Flow Index
86.40
MACD
55.06
MACD Signal
38.27
Average True Range
42.50
Average Directional Index
41.47
Rate of Change (21)
35.84
Rate of Change (125)
57.94

Vimta Labs Ltd Company background

Founded in: 1990
Managing director: Harita Vasireddi
Vimta Labs Ltd., established in 1984, is Indias most comprehensive contract research and testing organization, providing wide range of services to pharmaceutical, biopharmaceutical, food, consumer goods, electronic, electrical, agrochemical, healthcare, medical device and many other industries. Broadly, these services include: Drug discovery, development and drug life cycle management support services in the areas of preclinical research (GLP and nonGLP), clinical research, central lab, and cGMP as well as nonGMP analytical services for pharmaceutical and biopharmaceutical companies Preclinical research and testing services for medical device companies Contract research and testing for Agroscience companies Food testing and analytical development services to support manufacturers, processors, farmers, retailers, traders, exporters, regulators Clinical diagnostics services to patients, clinicians, hospitals and Environmental regulatory services such as impact assessments and post project monitoring, to industries such as infrastructure, power, cement, oil gas, mining etc EMI/EMC testing for electronic and electrical products.In 1997, the Company entered into a Joint Venture with Russian Centre for Testing and Certification, ROSTEST Moscow with an investment of 24% of the total Paidup Captial. The main essence of this Joint Venture was to diversify the activities in to preshipment inspection services for all Indian exports to Russia.During 2002, the company began to offer Clinical Diagnostics Services. Clinical Specialty Diagnostics has been an internal requirement to screen the clinical trial subjects. Facilities were created in the year 2000 to speed up the clinical trials.During the year 200607, the Analytical and Clinical Reference Lab facilities was shifted from the existing Cherlapally Facility to the newly established Life Sciences Facility in S.P.Biotech Park, Genome Valley, Hyderabad which started commercial operations from September, 2006.During the year 2020 Company acquired 100% Equity Shares of Emtac Laboratories Private Limited, on 04th March 2020, making Emtac a wholly owned subsidiary of the Company.In 202324, Emtac Laboratories Private Limited got amalgamated with the Company effective 01.04.2024.
Read More

Vimta Labs Ltd FAQs

Vimta Labs Ltd shares are currently priced at 764.65 on NSE and 765.35 on BSE as of 11/19/2024 12:00:00 AM. Please be aware that stock prices are subject to continuous fluctuations due to various factors.

The past 1-year return of Vimta Labs Ltd [VIMTALABS] share was 78.44. The Vimta Labs Ltd [VIMTALABS] share hit a 1-year low of Rs. 390.3 and a 1-year high of Rs. 804.25.

The market cap of Vimta Labs Ltd is Rs. 1698.54 Cr. as of 11/19/2024 12:00:00 AM.

The PE ratios of Vimta Labs Ltd is 33.42 as of 11/19/2024 12:00:00 AM.

The PB ratios of Vimta Labs Ltd is 5.02 as of 11/19/2024 12:00:00 AM

You can easily buy Vimta Labs Ltd shares in Kotak Securities by opening a demat account and getting the KYC documents verified online.

Open Demat Account
+91 -

personImage
Open Demat Account
+91 -